| BAL | bronchoalveolar lavage |
| CNI | calcineurin inhibitors |
| CNS | central nervous system |
| CsA | Cyclosporine |
| CSF | cerebral spinal fluid |
| CMV | Cytomegalovirus |
| D+/D− | Toxoplasma-seropositive/seronegative donor |
| HSCT | allogeneic haematopoietic stem cell transplant |
| mTORI | mammalian target of rapamycin inhibitors |
| NCC | Neurocysticercosis |
| PCR | polymerase chain reaction |
| PTLD | post-transplant lymphoproliferative disorder |
| R+/R− | Toxoplasma-seropositive/seronegative recipient |
| SOLs | intracranial space-occupying lesions |
| SOT | solid organ transplantation |
| TAC | Tacrolimus |
| TB | Tuberculosis |
| TMP-SMZ | trimethoprim-sulfamethoxazole |
| WB | western blot |